Correction: Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014.

[This corrects the article DOI: 10.1371/journal.pntd.0005210.]

Knowledge, attitudes and practices about vaccination in surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.

<p>Knowledge, attitudes and practices about vaccination in surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.</p

Oral cholera vaccination (OCV) acceptability 1 month before the campaign (baseline) and campaign awareness and OCV uptake 3 months after the campaign (first follow-up), Maela Camp, 2013.

<p>Oral cholera vaccination (OCV) acceptability 1 month before the campaign (baseline) and campaign awareness and OCV uptake 3 months after the campaign (first follow-up), Maela Camp, 2013.</p

Reasons for household non-response in the surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.

<p>Reasons for household non-response in the surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.</p

Knowledge and practices about safe water, sanitation and hygiene in surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.

<p>Knowledge and practices about safe water, sanitation and hygiene in surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.</p

Differences in knowledge, attitudes and practices (KAPs) for surveys conducted 1 month before (baseline) versus 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign in Maela Camp, 2013.

<p>Absolute differences in proportions for KAP responses in the first and second follow-up surveys compared to baseline were calculated; error bars depict 95% Wald asymptotic confidence interval (CI). Statistically significant differences (CI not overlapping zero) are shown in grey; non-significant differences are shown in white. Outcomes marked with * have directionality of difference switched from Tables <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005210#pntd.0005210.t003" target="_blank">3</a> and <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005210#pntd.0005210.t004" target="_blank">4</a>, so that improvements are depicted in positive direction, and negative changes are depicted in negative direction.</p

Socio-demographic characteristics of respondent households in the surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.

<p>Socio-demographic characteristics of respondent households in the surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.</p

Multistate US Outbreak of Rapidly Growing Mycobacterial Infections Associated with Medical Tourism to the Dominican Republic, 2013–2014

During 2013, the Maryland Department of Health and Mental Hygiene in Baltimore, MD, USA, received report of 2 Maryland residents whose surgical sites were infected with rapidly growing mycobacteria after cosmetic procedures at a clinic (clinic A) in the Dominican Republic. A multistate investigation was initiated; a probable case was defined as a surgical site infection unresponsive to therapy in a patient who had undergone cosmetic surgery in the Dominican Republic. We identified 21 case-patients in 6 states who had surgery in 1 of 5 Dominican Republic clinics; 13 (62%) had surgery at clinic A. Isolates from 12 (92%) of those patients were culture-positive for Mycobacterium abscessus complex. Of 9 clinic A case-patients with available data, all required therapeutic surgical intervention, 8 (92%) were hospitalized, and 7 (78%) required ≥3 months of antibacterial drug therapy. Healthcare providers should consider infection with rapidly growing mycobacteria in patients who have surgical site infections unresponsive to standard treatment